Ottensmeier, Professor Christian
MD, PhD, FRCP
Thoracic malignancies, skin cancer, immunotherapy
Training and education
- Medical degree, 1986
- MD, Münster, Germany, 1989
- PhD, University of Southampton, 1999
- Certificate of completion of specialist training in medical oncology, 1997
Professor Ottensmeier has worked for the Trust since February 1994.
From 1991 to 1993, he was a research fellow at the Dana Farber Cancer Institute, Boston, USA. In 1999, Professor Ottensmeier took on the roles of senior lecturer and consultant in medical oncology. In 2007 he became a professor of experimental cancer medicine.
- Chair in experimental cancer medicine
- Cancer Research UK senior clinical research fellow since 1999
- Programme grant holder, Cancer Research UK
- Programme grant holder, Leukemia Resarch Fund
- Programme grant holder and lead, Experimental Cancer Medicine Centre, Southampton.
- McCann, K.J, Ashton-Key, M, Smith, K.A, Stevenson, F.K, and Ottensmeier, C.H.H (2008). Primary CNS lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development. Blood, in press.
- Ottensmeier, C.H.H, et al (2008). DNA fusion gene vaccination, delivered with or without in vivo electroporation - a potent and safe strategy for inducing anti-tumor immune responses in prostate cancer. In American Society of Gene Therapy, 11th Annual Meeting. (Boston, MA, USA), p. Abstract 450987.
- Rice, J, Ottensmeier, C.H, and Stevenson, F.K (2008). DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8, 108-120
- McCann, K.J, Johnson, P.W, Stevenson, F.K, and Ottensmeier, C.H (2006). Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event? Leukemia 20, 530-534.